Group One Trading, L.P. Immutep LTD Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.87 - $3.23 $52,591 - $90,840	28,124 Added 964.14%	31,041 $62,000
Q1 2024 May 10, 2024	SELL	$2.11 - $2.89 $1,550 - $2,124	-735 Reduced 20.13%	2,917 $6,000
Q4 2023 Feb 14, 2024	BUY	$1.76 - $2.49 $6,427 - $9,093	3,652 New	3,652 $8,000
Q1 2023 May 12, 2023	BUY	$1.63 - $2.06 $2,154 - $2,723	1,322 Added 92.71%	2,748 $4,000
Q4 2022 Feb 09, 2023	BUY	$1.6 - $2.53 $553 - $875	346 Added 32.04%	1,426 $2,000
Q3 2022 Nov 09, 2022	SELL	$1.56 - $2.29 $8,372 - $12,290	-5,367 Reduced 83.25%	1,080 $2,000
Q2 2022 Aug 11, 2022	BUY	$1.96 - $3.09 $12,636 - $19,921	6,447 New	6,447 $13,000

1.86M

264K

90.5K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $167M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.